Óscar Muñoz Moreno Arrones-rekin lankidetzan egindako argitalpenak (66)

2024

  1. Clinical Characterization and Treatment Response of Folliculitis Decalvans Lichen Planopilaris Phenotypic Spectrum: A Unicentre Retrospective Series of 31 Patients

    Acta Dermato-Venereologica, Vol. 104

  2. Hair follicle sulfotransferase activity and effectiveness of oral minoxidil in androgenetic alopecia

    Journal of Cosmetic Dermatology

  3. Impact of Finasteride and Dutasteride in Beard Thickness in Men With Androgenetic Alopecia: A 453-patient Retrospective Trial

    Actas Dermo-Sifiliograficas

  4. Low-Dose Oral Minoxidil Severe Adverse Effects as a Consequence of Compounding Errors

    Actas Dermo-Sifiliograficas, Vol. 115, Núm. 4, pp. T407-T408

2023

  1. Folliculitis Decalvans Has a Heterogeneous Microbiological Signature and Impaired Immunological Response

    Dermatology, Vol. 239, Núm. 3, pp. 454-461

  2. Genotyping of the rs1800440 Polymorphism in CYP1B1 Gene and the rs9258883 Polymorphism in HLA-B Gene in a Spanish Cohort of 223 Patients with Frontal Fibrosing Alopecia

    Acta Dermato-Venereologica, Vol. 103

  3. Low-Dose Oral Minoxidil Severe Adverse Effects as a Consequence of Compounding Errors

    Actas Dermo-Sifiliograficas

  4. Recommendations on the Clinical Management of Androgenetic Alopecia: A Consensus Statement From the Spanish Trichology Group of the Spanish Academy of Dermatology and Venererology (AEDV)

    Actas Dermo-Sifiliograficas

  5. Safety of Low-Dose Oral Minoxidil in Patients With Hypertension and Arrhythmia: A Multicenter Study of 264 Patients

    Actas Dermo-Sifiliograficas

2022

  1. Beard loss in men with frontal fibrosing alopecia

    Journal of the American Academy of Dermatology, Vol. 86, Núm. 1, pp. 181-183

  2. Before-after study with 24-hour ambulatory blood pressure monitoring after the first dose of 5 mg oral minoxidil

    Journal of the American Academy of Dermatology

  3. Imiquimod-enhanced immunotherapy with diphencyprone for patients with alopecia areata

    Dermatologic Therapy, Vol. 35, Núm. 7

  4. Low-dose oral minoxidil for treatment of androgenetic alopecia and telogen effluvium in a pediatric population: A descriptive study

    Journal of the American Academy of Dermatology, Vol. 87, Núm. 3, pp. 700-702

  5. Mesotherapy With Dutasteride for Androgenetic Alopecia: A Retrospective Study in Real Clinical Practice

    Journal of drugs in dermatology : JDD, Vol. 21, Núm. 7, pp. 742-747

  6. Serious Adverse effects From Compounding Errors With Low-Dose Oral Minoxidil for Alopecia Treatment

    Actas Dermo-Sifiliograficas, Vol. 113, Núm. 7, pp. 725-727

2021

  1. Characterization and management of hypertrichosis induced by low-dose oral minoxidil in the treatment of hair loss

    Journal of the American Academy of Dermatology, Vol. 84, Núm. 1, pp. 222-223

  2. Effectiveness of dutasteride in a large series of patients with frontal fibrosing alopecia in real clinical practice

    Journal of the American Academy of Dermatology, Vol. 84, Núm. 5, pp. 1285-1294

  3. Epidemiologic and clinical features of pattern III frontal fibrosing alopecia (pseudo fringe type): A multicenter series of 38 patients

    Journal of the American Academy of Dermatology, Vol. 84, Núm. 3, pp. 797-798

  4. Folliculitis decalvans microbiologic signature is specific for disease clinical phenotype

    Journal of the American Academy of Dermatology, Vol. 85, Núm. 5, pp. 1355-1357

  5. Histological evidence for epidermal and dermal atrophy of the alopecic band in treatment-naïve patients with Frontal Fibrosing Alopecia

    Journal of the European Academy of Dermatology and Venereology